What are exosomes and how can they be used in multiple sclerosis therapy?

Expert Review of Neurotherapeutics

Volumn 14, Issue 4, 2014, Pages 353-355

  Pusic, Aya D ^a   Pusic, Kae M ^a   Kraig, Richard P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Environmental enrichment; Exosomes; miRNA; Multiple sclerosis; Remyelination

Indexed keywords

MESSENGER RNA; MICRORNA; MYELIN; VACCINE;

BLOOD BRAIN BARRIER; BONE MARROW; CELL CULTURE; DENDRITIC CELL; EXOSOME; HUMAN; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REMYELINIZATION; REVIEW;

EXOSOMES; HUMANS; IMMUNOLOGIC FACTORS; MICRORNAS; MULTIPLE SCLEROSIS; PROTEINS; RNA, MESSENGER;

EID: 84896331977     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2014.890893     Document Type: Review

References (17)

1. Kuhlmann T, Miron V, Cui Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008;131(7):1749-58
2. Wiendl H, Toyka KV, Riekmann P, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG). Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol 2008;255(10): 1449-63
3. Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013;14(3):5338-66
4. Rountree RB, Mandl SJ, Nachtwey JM, et al. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res 2011;71(15):5235-44
5. Hartman ZC, Wei J, Glass OK, et al. Increasing vaccine potency through exosome antigen targeting. Vaccine 2011;29(50): 9361-7
6. Keller A, Leidinger P, Lange J, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009;4(10):e7740
7. Magalon K, Cantarella C, Monti G, et al. Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models. Eur J Neurosci 2007;25(3):761-71
8. Mattson MP, Duan W, Lee J, Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 2001;122(7):757-78
9. Kraig RP, Mitchell HM, Christie-Pope B, et al. TNF-a and microglial hermetic involvement in neurological health & migraine. Dose Response 2010;8(4): 389-413
10. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008;31(7):361-70
11. Pusic AD, Kraig RP. Youth and environmental enrichment generate serum exosomes containing mir-219 that promote CNS myelination. Glia 2014;62:284-99
12. Dugas JC, Cuellar TL, Scholze A, et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 2010;65(5):597-611
13. Zhao X, He X, Han X, et al. MicroRNAmediated control of oligodendrocyte differentiation. Neuron 2010;65(5):612-26
14. Junker A, Krumbholz M, Eisele S, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009; 132(12):3342-52
15. Shin D, Shin JY, McManus MT, et al. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 2009;66(6):843-57
16. Pusic AD, Pusic KM, Kraig RP. IFNg Stimulated Dendritic Cell Exosomes as a Potential Therapeutic for Remyelination. J Neuroinflammation 2014;266(1-2): 12-23
17. Williams JL, Gatson NN, Smith KM, et al. Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity. Clin Immunol 2013;149(2):236-43